On 5/18 we alerted Cerecor Inc. ($CERC) at $2.12 entry. 30 day average exit of $3.50 for a 65% gain. 

Cerecor is building a global biopharmaceutical enterprise with a near-term pipeline of 6 clinical assets and 8 ongoing clinical programs. All of the pipeline products have unique and novel mechanisms of action with the potential to be first-in-class compounds.

The focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.